Ge, X., Yu, L., Zhang, L., Jia, L., Meng, M., He, J., Bu, F., Song, Y., Sun, G., Lv, S., Mei, D., Yang, Y., Xu, D., Zhang, J., Zhang, S., Wang, C., Jia, D., Chen, Y., Gao, Y., He, B. (2025). Targeting LRBA triggers CTLA4 degradation and antitumor immunity for cancer immunotherapy. Nature Communications. https://doi.org/10.1038/s41467-025-67365-5